Maxigen Biotech Inc (1783) — Strategic Asset Allocation Index
Maxigen Biotech Inc (1783) has a Strategic Asset Allocation Index of 33.5% as of December 2022. Strategic assets (PP&E of NT$434.62 Million plus long-term investments of NT$-) total NT$434.62 Million, measured against net assets of NT$1.30 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Maxigen Biotech Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Maxigen Biotech Inc Strategic Asset Allocation Index (2015–2022)
This chart shows how Maxigen Biotech Inc's Strategic Asset Allocation Index has evolved across 8 annual periods from 2015 to 2022. As of December 2022, the index stands at 33.5%, representing strategic assets of NT$434.62 Million against net assets of NT$1.30 Billion TWD. See Maxigen Biotech Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Maxigen Biotech Inc (2015–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Maxigen Biotech Inc from 2015 to 2022, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Maxigen Biotech Inc (1783) market capitalisation.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 33.5% | NT$434.62 Million | NT$434.62 Million | NT$- | NT$1.30 Billion | ▼ -7.2 pp |
| 2021 | 40.8% | NT$465.45 Million | NT$465.45 Million | NT$- | NT$1.14 Billion | ▼ -15.2 pp |
| 2020 | 56.0% | NT$481.52 Million | NT$481.52 Million | NT$- | NT$860.23 Million | ▼ -3.0 pp |
| 2019 | 59.0% | NT$502.09 Million | NT$502.09 Million | NT$- | NT$851.32 Million | ▲ +0.4 pp |
| 2018 | 58.6% | NT$494.03 Million | NT$494.03 Million | NT$- | NT$842.98 Million | ▼ -4.4 pp |
| 2017 | 63.1% | NT$502.05 Million | NT$502.05 Million | NT$- | NT$796.25 Million | ▼ -1.3 pp |
| 2016 | 64.4% | NT$503.19 Million | NT$503.19 Million | NT$- | NT$781.38 Million | ▲ +10.7 pp |
| 2015 | 53.7% | NT$446.00 Million | NT$446.00 Million | NT$- | NT$829.86 Million | — |